Digital Exclusives
Is health insurance consolidation good for the consumer? Mounting evidence suggests that pricing and quality of care are negatively, and increasingly, impacted.
A dose of business principles, in large part from venture philanthropy, is changing the way medical research is done in the U.S. health care industry.
Are recent health care mergers a good thing? Who are the winners and losers in these deals? Jeff Voigt finds answers in research on past consolidations.
As part of the Affordable Care Act, primary care providers got paid more to take Medicaid patients. Did it work to provide better care to more people?
A Wharton health care expert shares a recent scare with his father, when he learned firsthand how fragmented health care delivery is despite the ACA.
Could health gains from the ACA be in jeopardy from reluctance to continue state-based Medicaid payments? A Wharton Health Care Management alum sounds off.
Academic medical centers face a long list of tasks to survive in the 21st century U.S. health care system, writes Wharton’s alumni health care club president.
The U.S. federal government has rolled out new implementation goals for value-based health care payments. Are regulators moving too far, too fast?
Health information technology is hot, but its growth comes at the expense of medical devices, writes the health care-focused Wharton alumni club president .
With upward of 39 million more Americans receiving health care coverage through health care reform, will the system be able to meet the demand?
Wharton alumni are right in the thick of meaty health care issues, like the cost of specialty drugs. Here’s a recap of some notable graduates talking about the topic for SiriusXM.
A celebration of the values and the people of Wharton’s Health Care Management Department.
The health care capabilities of Apple’s ”most personal device ever” could boost a marketplace filled with promising startups, says a medical device specialist.
Health care expert Jeff Voigt looks at a controversial liver drug to illustrate the growing importance of medical cost-effectiveness.
What does Massachusetts’ decision on Partners Healthcare mean for physicians and their patients? The Wharton Health Care Alumni Association president explains.
A Wharton blogger makes a call for greater transparency for the federal health care agency, particularly when patient outcomes and cost reductions are concerned.
